Corcept Therapeutics, Inc. (CORT)
40.47
+6.65
(+19.66%)
USD |
NASDAQ |
Mar 25, 16:00
40.50
+0.03
(+0.07%)
After-Hours: 20:00
Corcept Therapeutics Cash from Investing (Quarterly) : -11.84M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | -0.071M |
| Integer Holdings Corp. | -35.47M |
| Harrow, Inc. | -4.73M |
| Ultragenyx Pharmaceutical, Inc. | -72.25M |
| Cytokinetics, Inc. | -71.19M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 38.45M |
| Cash from Financing (Quarterly) | -31.22M |
| Free Cash Flow | 141.78M |
| Free Cash Flow Per Share (Quarterly) | 0.3204 |
| Free Cash Flow to Equity (Quarterly) | 38.65M |
| Free Cash Flow to Firm (Quarterly) | 38.40M |
| Free Cash Flow Yield | 2.92% |